Cannabis Microbial Safety testing is flawed

What is it about?

Current microbial testing methods rely on non specific culture based techniques. These culture based systems fail to detect microbial threats and have unknown false positive rates. Using DNA based techniques we discover microbial threats that were unknown to exist in cannabis samples. These microbes can potentially synthesize Paxilline and Citrinin both of which can co-extract and interfere with Cannabinoids. This study only found the genes that synthesize these compounds. Further studies are required to quantify the expression of these compounds.

Featured Image

Why is it important?

Cannabis is estimated to become a $20B market by 2020. Much of this market is medical use within health compromised individuals. Better safety testing in this field can have a large economic impact.